Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Dongguan Xiaofan Innovation Technology Co. Ltd. is managing 1 pending office action within the Chemistry & Materials technology area. This matter is assigned to 1 distinct examiner and is located within 1 distinct art unit. The current state of the portfolio shows a focused prosecution effort on this single action.
The busiest examiner for the company is CHORBAJI, MONZER R, who is responsible for 1 busiest examiner pending action. Since the portfolio only contains 1 pending office action, this examiner oversees all active matters. This creates a direct line of communication for the applicant.
Practitioners should focus on the 1 pending office action and the specific examination style of CHORBAJI, MONZER R. Successfully navigating the 1 distinct art unit will be key to advancing the company's Chemistry & Materials portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHORBAJI, MONZER R | 1 | 76.3% | +21.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19015683 | Aromatherapy device | CHORBAJI, MONZER R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19015683 | Aromatherapy device | CHORBAJI, MONZER R | — |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19015683 | Aromatherapy device | CHORBAJI, MONZER R | 1799 | §102§112 | Non-Final OA | — | Pending | Jan 10, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDongguan Xiaofan Innovation Technology Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Monzer R Chorbaji has the most, with 1 of Dongguan Xiaofan Innovation Technology Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.